A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+57.9%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$307M
AUM Growth
+$307M
Cap. Flow
-$103M
Cap. Flow %
-33.58%
Top 10 Hldgs %
96.9%
Holding
19
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
PCVX icon
Vaxcyte
PCVX
$103M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$96.8M 31.54%
2,019,057
-2,149,661
-52% -$103M
VRNA
2
Verona Pharma
VRNA
$9.16B
$64.2M 20.92%
2,457,500
– –
VERA icon
3
Vera Therapeutics
VERA
$1.38B
$57.3M 18.66%
2,960,231
– –
HLVX icon
4
HilleVax
HLVX
$105M
$30.8M 10.02%
1,838,486
– –
ACET icon
5
Adicet Bio
ACET
$59.9M
$18.9M 6.16%
2,115,385
– –
PHAT icon
6
Phathom Pharmaceuticals
PHAT
$864M
$16.1M 5.25%
1,435,106
– –
OKUR
7
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$4.83M 1.57%
2,073,957
– –
SIEN
8
DELISTED
Sientra, Inc.
SIEN
$3.4M 1.11%
1,673,589
– –
JSPR icon
9
Jasper Therapeutics
JSPR
$45.5M
$2.72M 0.89%
5,628,558
– –
SLNO icon
10
Soleno Therapeutics
SLNO
$3.6B
$2.38M 0.78%
1,201,506
– –
NCNA
11
NuCana
NCNA
$6.09M
$2.2M 0.72%
3,333,333
– –
EFTR
12
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.06M 0.67%
4,822,114
– –
SPRB
13
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.97M 0.64%
1,792,518
– –
PRTK
14
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.95M 0.63%
1,041,131
– –
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
$822K 0.27%
131,036
– –
XCUR icon
16
Exicure
XCUR
$35.4M
$324K 0.11%
281,636
– –
SYRE icon
17
Spyre Therapeutics
SYRE
$996M
$108K 0.04%
240,500
– –
MTEM
18
DELISTED
Molecular Templates, Inc.
MTEM
$66K 0.02%
200,000
– –
OBSV
19
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12.8K ﹤0.01%
87,999
– –